Le JDB : Pascal Prigent, (DG de Genfit) & Frédéric Gomez (Pharmium Securities)

from Le Journal des Biotechs · host BOURSORAMA

Dans ce numéro du journal des biotechs, Frédéric Gomez, analyste chez Pharmium Securities fait un focus sur trois dossiers : DBV Technologies, Inventiva, Median TechnologiesL'entretien est consacré à Pascal Prigent, directeur général de Genfit. Il détaille notamment la stratégie du groupe dans de nouvelles indications avec le lancement d'essais cliniques d'ici la fin de l'année.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Episode metadata supplied by the publisher feed · Published May 20, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

Le JDB : Pascal Prigent, (DG de Genfit) & Frédéric Gomez (Pharmium Securities)

0:00 33:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Le Journal des Biotechs?

This episode is 33 minutes long.

When was this Le Journal des Biotechs episode published?

This episode was published on May 20, 2021.

Can I download this Le Journal des Biotechs episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!